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Antimicrobial Therapy for Otitis Media 
With Effusion ('Secretory' Otitis Media) 
Erdem I. Cantekin, PhD; Timothy W. McGuire, PhD; Terri L. Griffith , PhD 
Objective.-To determine the effectiveness of antimicrobial treatment for 
otitis media with effusion ("secretory" otitis media) in children. 
Data Source.-We report the reexamination of a previously published study 
by Mandel et al that evaluated the efficacy of a 2-week course of antimicrobials 
(amoxicillin trihydrate) with and without a 4-week course of an oral decongestant-
antihistamine combination in a double-blind, placebo-controlled, randomized 
trial involving 518 infants and children with otitis media with effusion. 
Data Synthesis.-At 4 weeks, amoxicillin efficacy as determined by a tym-
panometric criterion (P = .121) or by a measure of improvement in hearing 
(P = .311) was insignificant. Only by otoscopic judgment, which is shown to 
contain a systematic bias as used in this clinical trial, could an argument be 
made for a marginal efficacy of amoxicillin at the 4-week end point. Logistic re-
gression analyses of the combined effects of treatment and prognostic factors 
showed no significant differences between placebo- and antibiotic-treated 
groups for unilateral effusions and for bilateral effusions. When subjects with 
unilateral and bilateral effusions were combined , the estimated efficacy of an-
tibiotic treatment was 12.3% by otoscopy (P= .014) and 4.8% by tympanome-
try (P = .171). We also demonstrate the sensitivity of outcome to diagnostic 
measures used and provide statistical evidence questioning the validity of oto-
scopic observations in this study. Six weeks after the termination of amoxicillin 
therapy, the recurrence of effusion was two to six times higher in the 
amoxicillin-treated children than in those treated with placebo (P = .001 ), and 
resolution of effusion was not significantly different among antibiotic and 
placebo groups (1 3.6% and 11.3%, respectively; P = .477). 
Conclusions.-Amoxicillin with and without decongestant-antihistamine 
combination is not effective for the treatment of persistent asymptomatic 
middle-ear effusions in infants and children . 
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of Pediatric Otolaryngology, Children's Hospital of 
Pittsburgh (Dr Cantekin) ; Graduate School of Industrial 
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(Dr McGuire) ; and College of Business and Public Ad-
ministration, University of Arizona, Tucson (Dr Griffith). 
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Surgery, Chicago, Ill , September 22, 1987. 
Reprint requests to Department of Pediatric Oto-
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(JAMA. 1991;266:3309-3317) 
IN CURRENT medical practice, non-
surgical treatment of otitis media with 
effusion ("secretory" otitis media) is lim-
ited to few choices. 1 Antibiotics with 
and without decongestant-antihistamine 
combination are the most commonly used 
medications. The lack of efficacy of an 
oral decongestant-antihistamine combi-
nation for treating this condition in chil-
dren has been reported. 2 The present 
study was conducted at the Otitis Media 
Research Center (OMRC) in Children's 
Hospital of Pittsburgh, Pa, betweenJuly 
1981 and October 1984 to determine the 
efficacy of antibiotics with and without 
decongestant-antihistamine combination 
for otitis media with effusion, using an 
experimental design and patient popu-
lation similar to those in the previously 
reported decongestant-antihistamine 
trial. Two years after the termination of 
the trial, two separate manuscripts with 
opposite conclusions were submitted to 
the New England Journal of Medicine 
(NEJM) in June 1986. The first author 
of the present report was a co-principal 
For editorial comment see p 3333. 
investigator and a coauthor of the ear-
lier drafts of the first manuscript (by 
Mandel et al) but had disagreed with its 
analysis and conclusions. The first manu-
script (the official report of the OMRC), 
submitted by Mandel et al, 3 was accepted 
and subsequently published by the 
NEJM. Our manuscript, however, was 
returned without review according to 
the NEJM's editorial decision of pub-
lishing only the articles submitted by 
principal investigators. (This statement 
is based on a written communication 
[January 6, 1987) from the editor of the 
NEJM, Arnold S. Reiman, MD, to Rob-
ert L. Potter, JD. Dr Reiman wrote: "The 
important question, therefore, is not 
whose interpretation is correct . . . but 
rather who has the right to publish ... "!) 
Since 1986, the efforts of the University 
of Pittsburgh and Children's Hospital of 
Pittsburgh have been successful in cen-
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soring our manuscript from publication, Table 1.-~ of TrMtment Groupe by Patient Characteristic&• 
as discussed in detail elaewhere. ,.~ AB • DA Aa+PL P"L+PL Total Since otitia media ia a very common 
l!rvolled 178 168 172 518 
childhood diiea.ie, and ainct amoxicillin 
jg the most frequently prescribed anti- lbduclltdt 23 13 22 58 
biotic for this condition, the results re- ~ 155 155 150 460 
ported by Mandel et al are extremely $(rllificalion ¥el\etllN 
important to the medical community and • 7-23 mo SIi 53 48 159 
the public at large. Therefore, we be- 2-5 y 71 73 74 218 
lieve it is important to report this re-
•-12 y 26 29 28 83 
examination of their results . U sini the 
Duration °' effution, wk same data set, the analyses presented 0-3 29 25 24 71 
herein are substantially different in sev, 
... 26 25 24 75 
eral major aspects from thoie presented 
> I 48 52 52 152 by Mandel et al (eg, multiple outcome 
Unknown 1,2 53 50 155 
measures are examined, initial differ-
ences in prognostic factors among treat- Previous anlimicrobiall for lhia epilode ..,... M 56 52 162 
ment groups are accounted for, recur- No 101 99 98 298 
rence patterns amoni treatment iJ'OUJ>I ProerlOltic factor• are analyzed). Therefore, we think thi, Lalerality °' eflueiont 
second publication is warranted. Unilll&erll '4 64 50 178 
Today's rationale for usini antimicro- lileltral t1 91 100 282 
bial therapy for otitis media is based on Midck-Mr .-istic impedanc-t 
the following concepts and observations: 0-5.0 « 50 38 132 
(1) the commonly accepted but not 5.1-7.0 5e 54 54 164 
proven hypothesis is that nollluppura- > 7.0 61 48 58 157 
tive, "secretory" otitis media with ef- Not~ 4 3 0 7 
fusion is secondary to bacterial infection Heeringioatll 
of the middle-ear space6·7; (2) the type 0-10 10 13 9 32 
and frequency of bacteria recovered from 1Hl0 ~ 46 43 138 
these effusions are similar to those of 21-30 48 49 48 145 
bacteria found in acute middle-ear in- 31-40 32 26 34 92 
fectionss.11 ; (3) current medical practice > 40 9 10 8 27 
for treating acute otitis media is a gen- Not IT'IMIU~ 7 11 8 26 
erous course of antimicrobial3, althouih 
Other charact.,-istic•~ the efficacy of this treatment in reaolv- Sex 
ing effusion wu never eatabliahed in a M 101 102 100 303 
placebo-controlled, randomized, double- F 17 SI 56 171 
blind study, 1~ 16 and the willdom of such 
"ace 
medical manJliement hu been recently wt-. 112 113 11 4 339 
shown to be flawed1i-!ill; and (4) aome MonwNla 43 47 42 135 
clinical trials report a varyin&' range of Socioeconomic ttalll• 
efficacy of antimicrobial3 to treat otiti1 ~Olmiodie '5 81 89 255 
media with effusion. 21-30 ~ 13 69 81 193 
No(__, 10 10 6 26 
METHODS 5-'latenl,y 
Infants and children from 7 months to Winw 12 64 59 185 
12 years of age who were suspected of ~ « 49 45 138 
having otitis media with effuiion were Summer 25 21 17 63 
referred to this double-blind, placebo- FIii 27 26 35 .. 
controlled, randomized clinical trial from ~-.piralor;-lred ndon al initiel vieit 
the Ambulatory Care Center of Chil- No 111 118 102 331 
dren's Hospital and from private phy- 't'N « 39 53 136 
1icians in the community. After the en- u,.,_, 3 3 7 
rollment of 518 children, the clinical trial HiNoryql,,....._ ..... 
was stopped without reachini the oriJ- No • 18 13 39 Vee 150 142 143 435 inal target sample size of 1040 subject.I 
"-'i'I ~ because of an apparent significant di!- No 158 155 150 461 
ference in cure rates between the treat- Vee 2 4 6 12 
ment iJ'OUps. The study population, en- No(1'11C01ded 0 0 
rollment procedures, criteria for patient 
eligibility, random assignment, drui ad- ~ ~ ...,.. amoxieillin with ~tant-ilntihistamine combination (All + DA), amoxiciffin with 
ministration and compliance monitorini, placebo (M + ), and placebo with placebo (PL + L). tchildren miMillQ one or mora follow-up visits alter entry were excluded. 
follow-up observations, and issues re- tWhtn bcllll ..,. oonlained .«uaion by ~ mathods (tymp¥o()f1letry and Oloscopy), the ch<ld MS classified IS 
lated to other clinical procedure• were ~=two_,. -~ 10 ~ent child 's middle-Mr impedance measure in arbitrary units described in detail by MAndel et al1; ol ~ IOffllVY. 
therefore , only a brief summary of the  ltW'9lhold ii .._ Mr for pure-tone ..,erage or &peeCh awareness was used to represent child's 
essentials is provided herein. ... ic. ii ....... ~ IO normal 1-ing level (di HL). ,._. on tie -.1rom ,....,_ 3 conMting of patianta who-. evaluated at the 4--k visit. 
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T~ 2.-0utcome at 4 WNlcs by Oioecopy, by 
Ty~y, and by Change in Hearing Accofd-
ing to Treatment Group5 in 480 ChiJdr.ii• 
Aa+DA U + l'L l'L + l'L Total 
Oloscopyt 
Effusion 112 94 105 291 
Acute otitis 11 12 20 43 
Effusion lrN 52 411 25 126 
x' - 14.18, af - 4, P - .oos 
T ympanometryt 
Effu5ioo 111 117 117 352 
Acuteotitis 11 12 20 43 
Effusion frN 26 25 13 64 
x'~ 8 .29, df= -4 , P = .081 
Hearingi 
Same 117 85 83 265 . 
Wo<-.a 5 3 5 13 
Sett« 38 ~ 43 127 
x' - 2.34, df - 4 , P ~.sn 
*TrNtment groups were amoxicillin wilh ~ 
!ant-antihistamine combination (AB + DA), amoxicillin 
with placebo (All + Pl), and placebo with placebo 
(Pl + Pl). 
tEffusion-fr&e w/Ji«;t was defined as both ears being 
effusion 1,,,. by otoscopy. 
tSubjects with tympanogram tvi- 1, 2, 3, -4 , 15, II, 
or 1 O for both Nlli _,. claasil~ in the elfusion-frN 
group (based on 4511 children wilh tympanometric data). 
fFor 405 children, improllement in hearing is baMd 
on =imum change in pu,e-tone ..,.,age or speech 
awa<eness threshold from entry to 4-week visit ; it 
threshold remained within ± 1 O dB, hearing was consid-
ered unchanged (_,,.~ and 55 children did not haw 
paired observaliona and thus _,e excluded. 
The diagnosis of otitis media at entry 
and at each subsequent examination WIii\ 
based on the findings obtained by a "val-
idated" otoscopist (sensitivity 94%, spec-
ificity 66%) and on the results of tym-
panometry (sensitivity 95%, specificity 
70%). 31-36 Over 90% of the otoscopic ob-
servations were made by a single ob-
server. Hearin&' acuity was also assessed 
by detennining air-conduction and bone-
conduction thresholds at four frequen-
cies, as well IUl by measuring speech 
reception or awareness thresholds. 
These audiological testing procedurei; 
were described previously in detail. 37 
After entry evaluation, subjects were 
stratified according to age, duration of 
the effusion, and whether an antimicro-
bial drug had been administered for oti-
tis media during the preceding 60 days . 
Within each subgroup, patients were 
randomly assigned in blocks of three, in 
double-blind fashion , to the amoxicillin 
and deconi'estant-antihistamine combi-
nation ifOUP, the amoxicillin and pla-
cebo group, and the placebo and placebo 
group. A liquid suspension of amoxicil-
lin trihydrate (Amoxil, supplied by 
Beecham Laboratories, Bristol, Tenn) 
was administered in a dosage of 40 mg/ 
kg per day in three divided doses for 2 
weeks. The decongestant-antihistamine 
was a liquid preparation of pseudo-
ephedrine hydrochloride and chlorphe-
niramine maleate (Novafed A syrup, 
supplied by Merrell-Dow Pharmaceuti-
cals, Indianapolis, Ind), given at a dos-
age of 1.0 mg of pseudoephedrine hy-
drochloride and 0.09 mg of chlorphe-
niramine maleate per kiloifam of body 
weight. The medication was adminia-
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tered four times daily for 4 weeks. The 
corresponding placebos for amoxicillin 
and for the deconiestant-antihistamine 
were identical in appearance and simi-
lar in taste to the active medications. 
All medication was dispensed in double-
blind fashion. 
The subjects were reexamined ap-
proximately 2 weeks after entry and at 
the end of 4 weeks. The presence or 
absence of middle-ear effusion was de-
termined by otoscopy and by tympa-
nometry. At 4 weeks, hearing acuity 
was reassessed in the same manner as 
at entry. All observers were blinded 
with regard to each subject's treatment 
woup. In order to evaluate recurrences, 
patients whose middle-ear effusions had 
cleared during the 4-week study period 
were reexamined approximately 4 weeks 
after completion of the study. 
Proportions were compared with the 
use of x2 statistics. We also used logistic 
regression analysis to estimate the ef-
fect of antimicrobial therapy while con-
trolling for the differences in prognostic 
factors across treatment groups. Aver-
age power over the various outcome 
~alyses employed was large enough to 
detect at the .05 level of significance a 
10--percentage-point difference between 
the treatment groups with over 90% 
power. 
RESULTS 
,opulation Characteristics 
Five hundred eighteen children with 
unilateral or bilateral otitis media were 
~nrolled, of whom 460 were evaluated 
at both 2- and 4-week visits. The re-
maining 58 children did not return for 
either one or both of the follow-up visits 
ind thus were excluded from the data 
analysis . The distribution of subjects 
y.rithin the three randomization strata-
age, duration of effusion, and previous 
administration of antimicrobials-is 
:shown in Table 1. Also, the distribution 
of prognostic factors and other demo-
ifaphic and clinical characteristics con-
:sidered to have potential influence on 
outcome are depicted. 
Outcome at 4 WNks 
On completion of the chemotherapy 
•t 4 weeks, the middle-ear status was 
evaluated by otoscopy, tympanometry, 
and audiometric threshold. Table 2 
hows that differences between the out-
comes in antimicrobial-treated and pla-
cebo-treated groups were significant 
only when otoscopy was used as the di-
agnostic measure (P = .005). The differ-
ences between treatment groups were 
not significant when a tympanometric 
criterion for the clearance of middle-ear 
effusion was chosen (P - .081). More-
over, 32.8% of children in the placebo 
group showed improvement in hearing 
between entry and the 4-week visit, in 
contrast to 30. 7% of children who had 
improved hearing in the two antibiotic-
treated groups (P = .672). Durini' this 
period, 43 children were diagnosed by 
otoscopy and by clinical signs and symp-
toms as having an episode of acute otitis 
media. The incidence of acute otitis me-
dia was greater in the placebo group 
than in the antibiotic groups (13.3% vs 
7.1% and 7.7%, respectively; P= .122). 
The results presented in Table 2 in-
clude 460 patients with bilateral oto-
scopic and/or bilateral tympanometric . 
data during both visits at 2 and 4 weeks. 
Regardless of the initial laterality of ef-
fusion, only patients with bilateral ef-
fusion-free ears at the 4-week visit were 
classified in the no-disease category. A 
measure of improvement in hearing was 
available for children who had either 
pure-tone average or speech awareness 
thresholds at both entry and 4-week vis-
its. Improvement was defined as a 
threshold at least 10 dB lower at4 weeks 
than at entry. When bilateral pure-tone 
average data were available, the ear 
exhibiting maximum improvement wai; 
used to represent the improvement in 
the child's hearing. 
By the study protocol, the principal 
outcome was the proportion of children 
without effusion at the 4-week visit as 
determined by a diagnostic algorithm 
based on otoscopic and tympanometric 
findings described previously. 32 The ob-
served disparity between the objective 
(tympanometry, hearing) and subjective 
(otoscopy) measures as shown in Table 
2 prompted us to conduct a sensitivity 
analysis. We examined the outcome at 
4 weeks using the above-mentioned al-
gorithm as well as six other measures to 
estimate the efficacy of amoxicillin at 
this time point. The sensitivity analysis 
in Table 3 reveals that the estimated 
efficacy of amoxicillin is relatively in-
consequential-7.8% or less-and with-
out statistical significance by all out-
come measures that are not heavily in-
fluenced by otoscopy. Only for the pure 
otoscopy measure and for the algorithm 
are the estimated efficacies greater than 
10% (16.0% and 11.7%; P= .004 and 
P= .027, respectively) if the outcome is 
not corrected for the preponderance of 
unfavorable prognostic factors for the 
placebo group. With correction, the ef-
ficacy is 9.1% (P"" .040) using the algo-
rithm. 
In this analysis and the ensuing anal-
yses of prognostic factors, we have omit-
ted 43 cases for which acute otitis media 
was diagnosed during this 4-week pe-
riod. Omission of those subjects was 
thought to be justified for the following 
reasons: (1) the purpose of this study 
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Table 3.-Sensitivity Analysis of Outcome at 4 Weeks* 
Treatment Groupst 
AB + DA AB + PL PL + PL % 
Outcome Measure (n=144) (n=142):t (n=130) Difference Probability 
Otoscopy 36.1§ 34.3 19.2 16.011 .004~ 
Algorithm# 26.4 24.6 13.9 11.7 .027 
Tympanometry 18.1 17.6 10.0 7.8 .121 
Otoscopy and tympanometry•• 15.3 12.6 8.5 5.5 .225 
Normal hearingtt 23.0 20.9 18.0 3.9 .611 
Hearing improvement:j::j: 27.1 36.0 32.5 - 1.0 .311 
Combined criterion§§ 11 .5 9.0 6.6 3.7 .381 
*Excluding 43 children who had developed acute otitis media during the 4-week period. 
tGroups were amoxicillin with decongestant-antihistamine (AB + DA), amoxicillin with placebo (AB + PL), and 
placebo with placebo (PL + PL). 
1:For otoscopy, an additional subject for whom tympanometric data are missing is included. 
§Percentage of the treatment group that is effusion free or with normal or improved hearing or both. 
IIDifference between the placebo group and the combined antibiotic groups. 
~Calculated by x' statistics using three treatment groups and two outcome categories. 
#Combination of otoscopy and tympanometry according to the algorithm described in the original study protocol 
(reference 32 with tympanogram type 12 with negative otoscopy as indicative of effusion using Bayesian estimates) 
and not employed by Mandel et al' in their analyses of outcome. 
**Effusion free by both methods (tympanometry and otoscopy). 
ttHearing loss in either ear not exceeding 1 O dB HL; sample sizes were 139, 134, and 122, respectively. 
:j::j:As defined in Table 2; sample sizes were 129, 125, and 114, respectively. 
§§Effusion free by both methods and hearing loss in either ear not exceeding 1 O dB HL; same sample size as in 
footnote tt. 
Table 4.-Logistic Regression Analyses of Combined Effects of Antibiotic Treatment and Prognostic Factors 
on Patient Cure Rate by Initial Laterality of Effusion According to Otoscopic and Tympanometric 
Measurements 
Otoscopy Tympanometry 
Unilateral Bilateral* Total Unilateral BIiaterai Total 
Antibiotic treatment .060t .108 .014 .1 00 .748 .171 
Hearing loss .400 .002 .001 .062 .014 .004 
Middle-ear acoustic .100 .669 .463 .015 .534 .019 
impedance 
Laterality .034 .933 
Estimated antibiotic 18.3 10.1 12.3 6.8 1.5 4.8 
efficacy,% 
Reduction in efficacy 2.7 1.3 3.7 6.6 2.2 3.0 
due to prognostic 
factors,% 
Sample size:j: 144 246 390§ 144 245 389 
*Initially, when both ears contained effusion by both methods (tympanometry and otoscopy), the child was 
classified as having bilateral effusions. 
tP values for logistic regression are shown. 
:j:Sample sizes exclude 43 children who developed acute otitis media and 27 children with missing initial data on 
either hearing loss or acoustic impedance. 
§For otoscopy, an additional subject for whom tympanometric data are missing is included. 
was not to estimate the prophylactic ef-
ficacy of antimicrobial treatments, (2) 
acute otitis media is a common occur-
rence in this age group that is exter-
nally triggered and is not controllable 
within the study design, and (3) many of 
those children were treated with addi-
tional antimicrobials. 
Prognostic and Diagnostic Factors in 
Relation to Outcome 
Certain prognostic factors identified 
at the initial visit had significant effects 
on a child's status at the 4-week visit. 
Hearing loss and acoustic impedance of 
the middle ear were strongly associated 
with the outcome. The relationships be-
tween these two prognostic factors and 
cure rate found by otoscopy and tym-
panometry are illustrated in Fig 1. Large 
hearing loss or increased acoustic im-
pedance due to mass loading of the mid-
die cavity was significantly related to 
poor outcome. 
Relationships between these prognos-
tic factors and outcome at the 4-week 
visit were investigated to identify pos-
sible confounding factors. We believed 
that it might be important to control for 
the combined effect of differences in poor 
prognostic factors across treatment 
groups, because these factors have sig-
nificant individual effects on outcome 
and because it happened by chance that 
in almost every case prognostic factors 
were worse for the placebo group than 
for the antibiotic-treated groups. For 
example, more children in the placebo 
group had bilateral effusions at entry 
than those in the other groups (66. 7% vs 
58.7%). 
For the analysis presented in Table 4, 
both antibiotic-treated groups were com-
bined, since these two groups showed 
..... 
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Fig 1 . - Effect of prognostic factors on cure rate at 
4-week visit by otoscopy and by tympanometry: ini-
tial middle-ear acoustic impedance (top) and initial 
hearing loss (bottom). Data points are the boxcar 
average values for one fifth of the sample without 
acute otitis cases and lines are the linear regression 
fits based on all observations (n = 390) , not just the 
five average values plotted. 
similar results (see Tables 2 and 3). In 
this model the population was split into 
two ex ante identifiable subsamples: ini-
tial unilateral disease only and initial 
bilateral disease only. Curing two ears 
is fundamentally different from curing 
one ear. Since the observation unit is 
the patient, these two subpopulations 
exhibit significantly different cure rates. 
The differences between cure rates in 
the unilateral and bilateral disease are 
significant at the .001 level by otoscopy 
and the .01 level by tympanometry. 
The logistic regression results, which 
include the effects of prognostic factors 
on the outcome, are summarized in Ta-
ble 4. At the P :s;; .Ol level, none of the 
estimated effects for antibiotics are sig-
nificant. When tympanometry is used 
as the diagnostic measure, the effects of 
antimicrobial treatment are insignificant 
(P= .100,. 748, and .171) and have small 
estimated efficacies (6.8%, 1.5%, and 
4.8%) for the unilateral, bilateral, and 
pooled samples, respectively. Even 
when the algorithm specified in the pro-
tocol is used as the diagnostic measure, 
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Table 5.-Subject Response Patterns Including 2-, 
4-, and 8-Week Visits by Otoscopy and by Tympa-
nometry According to Treatment Group in 460 
Children• 
AB+DA AB + PL PL + PL Total 
Otoscopy 
Persistence 77 80 90 247 
Recurrence 29 22 13 64 
Acute otitis 13 16 21 50 
Clearance 36 37 26 99 
Differences in clearance: x'= 2.33, d/= 2, P =.312 
Differences in recurrencet : x' = 6.44, di = 2, P = .040 
Tympanometry 
Persistence 103 98 109 31 O 
Recurrence 21 17 3 41 
Acute otitis 13 16 21 50 · 
Clearance 18 24 17 59 
Differences in clearance: x'= 1.48, d/= 2, P= .477 
Differences in recurrencet: x'= 13.74, d/= 2, P= .001 
*Persistence indicates otitis media with effusion dur-
ing all visits; recurrence, presence of effusion after 
clearance at 2- or 4-week visit ; and clearance, effusion 
free at last visit or visits without recurrence. By protocol, 
only patients without otitis media with effusion at the 4-
week visit returned for the 8-week visit. Treatment 
groups were amoxicillin with decongestant-antihista-
mine combination (AB + DA), amoxicillin with placebo 
(AB + PL), and placebo with placebo (PL + PL). 
tRecurrence with respect to the total population. 
the estimated efficacy was only 9.1 % 
(P = .040). An effect can be demon-
strated only when the unilateral and bi-
lateral disease cases are pooled into a 
single combined sample and otoscopy is 
used as the diagnostic measure 
(P= .014). The estimated antimicrobial 
treatment efficacy is 12.3% in this case; 
the reduction in efficacy of 3. 7 percent-
age points (from 16.0%; see Table 3) is; 
the result of statistically standardizing 
for differences in prognostic factors . 
Patient Response Pattern 
In this study, subjects who were free 
of effusion at the 4-week end point by 
otoscopic diagnosis were reexamined ap-
proximately 4 weeks later. Taking ad-
vantage of this repeated measure in the 
study design, we evaluated patterns of 
patient response to antimicrobial ther-
apy (which was terminated at 2 weeks) 
using 2-, 4-, and 8-week visits. The re-
sponse patterns are summarized in Ta-
ble 5. By otoscopic diagnosis, 23.5% of 
children treated with amoxicillin and 
17.3% of children who had placebo were 
disease free during this 6-week interval 
(P = . 312). Using the tympanometric cri-
terion to define disease-free children, 
the antibiotic groups and the placebo 
group were very similar (13.6% vs 11.3%; 
P= .477). These findings do not support 
the hypothesis that antimicrobial treat-
ment might have a beneficial but de-
layed effect. On the contrary, recurrence 
rates were two to six times larger in the 
antimicrobial-treated groups than in the 
placebo group by otoscopy (P = . 040) and 
by tympanometry (P= .001), respec-
tively, as shown in Table 5. If the re-
currence rates are calculated conditional 
on children who were effusion free at 
the 2- or 4-week visit, then the recur-
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rence rates by tympanometry were 
47.5% for the combined antimicrobial-
treated group and 15.0% for the placebo 
group (P < .01 ). 
Period of Observation, 
Compliance, and Side Effects 
The actual interval between entry into 
the trial and evaluation at 4 weeks- the 
period of observation-and compliance 
with medication requirements are dis-
cussed in detail in the report by Mandel 
et al. 3 These two parameters were not 
related to outcome, and the differences 
with respect to compliance and period of 
observation were insignifi'cant among 
the treatment groups. 
Commonly reported side effects by 
parents were mild sedation or irrita-
tion, with occasional incidence of diar-
rhea and rash. In the antibiotic-treated 
groups, these side effects were reported 
in 15% of the children who were also 
treated with decongestant-antihistamine 
combination and in 9% of those children 
t reated with amoxicillin alone. In the 
placebo-treated group, side effects were 
reported for 6% of the children. 
COMMENT 
Comparison With Study by 
Mandel et al, 1987 
The present report, based on reex-
amination of the database of the clinical 
trial reported by Mandel et al, 3 reveals 
opposite conclusions, ie, lack of efficacy 
of amoxicillin for treatment of otitis me-
dia with effusion in children. The pur-
ported efficacy of amoxicillin could not 
be demonstrated by our analysis of the 
same data. Our presentation of the data 
from this clinical trial contradicts as well 
as augments the information dissemi-
nated by the report by Mandel et al in 
several aspects. 
Mandel et al base their primary re-
sults and conclusions on the proportion 
of children determined to be effusion 
free at 4 weeks by the combination of 
otoscopic and tympanometric findings 
using an algorithm cited in the "Meth-
ods" section of their study. 33 The algo-
rithm Mandel et al employed is, how-
ever, not the algorithm described in the 
original study protocol32•33; it is not val-
idated based on some "gold" standard 
such as myringotomy34; and it is an al-
gorithm in which over 90% of the deci-
sions are based on the subjective mea-
sure of otoscopy alone. 34 
We attempted to replicate the pri-
mary end-point findings of Mandel et al 
using the method they describe to as-
sess middle-ear status; however, we 
were unable to do so. In the NEJM 
article (Table 2), Mandel et al show 118 
children as "cured" at the 4-week visit. 
Applying conservatively the algorithm 
they claimed they have used, we found 
only 88 "cured" children at the 4-week 
visit. (For example, in 12 cases, when 
the algorithm required the acoustic re-
flex measurement to determine the out-
come, those measures for reflex were 
missing. This is a condition where otos-
copy was recorded to find the ear effu-
sion free, with a tympanogram type 12 
associated with a .91 probability of ef-
fusion for the same ear. These 12 cases 
were counted as "cured" by Mandel et 
al, notwithstanding the high probability 
of effusion by tympanometry. In 16 other 
cases with positive tympanometry and 
negative otoscopy, middle-ear status de-
teriorated from the initial visit to the 
4-week visit, but those patients were 
also counted as "cured" by Mandel et 
al.) If the statistical analysis of Mandel 
et al in the NEJM article is applied to 
88 "cured" children, amoxicillin's effi-
cacy is reduced from 16.1 % to 10.5%, 
and the significance of the P value di-
minishes from P < .001 to P = .05. 
Our results using otoscopy alone are 
in agreement with the conclusions of 
Mandel et al. Our sensitivity analysis 
shown in Table 3 demonstrates that only 
with otoscopy can an argument be made 
about a statistically significant antibi-
otic efficacy. Other combinations to mea-
sure outcome, including the original 
study protocol algorithm, show either 
marginal or insignificant differences. 
Further examination of the outcome at 
4 weeks via logistic regression analysis 
reveals that prognostic factors have a 
significant effect on the results (Table 
4); correcting statistically for these dif-
ferences in prognostic factors reduces 
estimated efficacy by 1.3 to 6.6 percent-
age points. The role of initial hearini 
loss and acoustic impedance on the out-
come, not examined by Mandel et al, 
shows that the differences in cure rate 
between antibiotic and placebo groups 
are further reduced when those prog-
nostic factors are included. After this 
adjustment, even with otoscopic results, 
the estimated antibiotic efficacy is re-
duced from 16.0% to 12.3%. 
In addition to the 4-week outcome, 
we also have included an analysis of pa-
tient response patterns based on all data 
from 2-, 4-, and 8-week visits (Table 5). 
This section also addresses the recur-
rence issue and concludes that children 
treated with amoxicillin had more re-
currences than children who received 
placebo within a 6-week period after ter-
mination of the antimicrobial therapy. 
The report by Mandel et al does not 
expose the fact that there is a recur-
rence problem with amoxicillin-treated 
children that is greater than the recur-
rence found in placebo-treated children. 
Mandel et al also fail to mention that, 
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even with otoscopic measure, there were 
no statistically significant differences 
among the treatment groups with re-
spect to children who remained effusion 
free at the 8-week visit. 
Comparison With Other OMRC 
Studies 
Following the early termination of this 
clinical trial with only one half of the 
target sample size, the OMRC between 
1984 and 1987 conducted the second 
phase of this study using the same de-
sign but with four treatment arms. The 
OMRC kept the placebo and amoxicillin 
groups but added two additional anti-
biotic groups, Pediazole (erythromycin, 
ethylsuccinate-sulfisoxazole) and cef-
aclor, for the second clinical trial. Once 
again, the OMRC terminated the clin-
ical trial without reaching the target 
sample size, when the OMRC discov-
ered that the placebo group and the three 
antibiotic-treated groups had virtually 
the same cure rates at the 4-week end 
point. 'ix With a sample size of 310 sub-
jects, cure rates were 26. 7%, 29. 9%, 
25.0%, and 33.3% for placebo-, amoxi-
cillin-, Pecliazole-, and cefaclor-treated 
groups, respectively. '1~ 
At the time of the publication of the 
study by Mandel et al in the NEJM in 
February 1987, the OMRC was in pos-
session of those second-phase data, and 
those data indicate that amoxicillin was 
not effective and that two other antibi-
otics, Pediazole and cefaclor, also were 
not effective according to the method of 
analysis the O MRC had chosen to use. :ix.:ir, 
Nevertheless, the OMRC published the 
report by Mandel et al in the NEJM, 
knowing that the second-phase data did 
not support but contradicted the con-
clusions of the report by Mandel et al. 
The results of the second phase have 
never been published. 
A curious result in the report by Man-
del et al is the 4-week cure rate (14.1 %) 
for the placebo control group. It was 
significantly less than those encountered 
in an earlier study of the OMRC (de-
congestant-antihistamine) and in the sec-
ond phase of the antibiotic trial (24.0% 
and 26. 7%, respectively; P =. 022). Be-
tween 1981 and 1987, the OMRC com-
pleted three randomized, placebo-con-
trolled clinical trials evaluating the ef-
ficacy of decongestant-antihistamines 
and antibiotics for otitis media with ef-
fusion with 4-week sample sizes of 553, 
474, and 310, respectively. Those trials 
had nine treatment groups with the fol-
lowing 4-week cure rates: 24.0%, 14.1%, 
and 26. 7% (for the three placebo groups); 
and 24.5%, 28.8%, 31.6%, 29.9%, 25.0%, 
and 33.3% (for the six active treatment 
groups). Among those nine groups, only 
the placebo group in the report by Man-
de! et al is strikingly different (P = . 018). 
This anomalous cure rate in the pla-
cebo group, however , is not discussed 
by Mandel et al. We speculate that it is 
the result of a preponderance of poor 
prognostic factors in that placebo group 
(more bilateral disease, larger hearing 
losses, higher acoustic impedance val-
ues). Such a malclistribution of prognos-
tic factors can result from either im-
proper randomization or other problems 
related to group assignments. Mandel 
et al neither try to explain nor statis-
tically correct for this problem. 
Between January 1984 and May 1985, 
the OMRC conducted another clinical 
trial to evaluate the relative effective-
ness of a new antibiotic, Augmentin 
(amoxicillin trihyclrate-clavulanate com-
bination), in comparison to amoxicillin 
for otitis media with effusion. This clin-
ical trial also was patterned after the 
report of Mandel et al but without a 
placebo control group. The study sub-
jects were enrolled and evaluated by 
two private pediatric practice groups 
outside Children's Hospital of Pittsburgh 
on a fee-for-subject basis arrangement. 
This trial was supported by the manu-
facturer of the new antibiotic. 
The findings of this clinical t rial in-
volving 108 children were published by 
the OMRC in 1988, with Chan et al28 
concluding that both antibiotics (Aug-
mentin and amoxicillin) were equally ef-
fective. According to Chan et al, the 
cure rate for amoxicillin-treated subjects 
at the 4-week encl point was 51.5%. This 
result was significantly better than the 
28.8% cure rate reported for the amox-
icillin-treatecl group by Mandel et al, 
who used the identical method of anal-
ysis. Chan et al inexplicably fail to men-
tion this significant difference (P = . 005) 
between the two amoxicillin-treatecl 
groups. When the 4-week encl point in 
the study by Chan et al is evaluated 
using tympanometric results, however, 
the studies by Chan et al and Mandel et 
al yield almost identical cure rates (19.2% 
vs 17.6%). This discrepancy between the 
subjective measurements (otoscopy) and 
objective measurements (tympanome-
try) illustrates nicely the clangers in re-
lying on subjective measurements to de-
fine the outcome of non-placebo-con-
trolled clinical trials. The otoscopists in 
the study by Chan et al knew t hat both 
groups were receiving antibiotics and 
managed to see "cures" almost twice as 
frequently as the otoscopists in the study 
by Mandel et al and almost three times 
as frequently as tympanometric cure 
rates. 
Bias in Otoscopy 
One of the most puzzling aspects of 
the present findings was the difference 
in results by otoscopy and by tympa-
nometry . In a study published by Maw 
and Herod, 40 no such significant differ-
ence appears. In the present study, how-
ever, twice as many children were 
judged to be effusion free at the 4-week 
visit by otoscopy as by tympanometry 
(27.4% vs 13.9%; P < .001). 
The difference in cure rates between 
the treatment groups (efficacy) is shown 
in Table 3 for various outcome measures 
(sensitivity analysis). Efficacies as de-
termined by otoscopy and by tympa· 
nometry were 16.0% and 7.8%, respec-
tively. When the entry imbalance of 
prognostic factors is corrected for, those 
figures are further reduced to 12.3CJ 
and 4.8% (Table 4). The overlap in ef-
ficacy between otoscopy and tympanom-
etry was 5.5% (Table 3, row 4 and col-
umn 4) , resulting in 18.3% and 5.iio/c 
upper and lower bounds. These values 
are reduced to 13.3% and 3.8% when 
corrections for prognostic factors are 
included. 
We hypothesized that the dispa1ity 
between otoscopic and tympanomet1ic 
results could be explained in part by the 
fact that the otoscopist observed both 
ears before recording the results. This 
knowledge, we hypothesized, might well 
bias the otoscopist in the direction of 
judging both ears the same. The tym-
panometry, of course, could not have 
that bias. 
The probability of effusion associated 
with a given tympanogram is well known 
from prior work. 34 If otoscopy measures 
were unbiased, one would expect the 
proportion of ears that are judged to 
have effusion by otoscopy not to be dif-
ferent from the known tympanomet1ic 
probability of effusion. In other words. 
for a given tympanogram type, the dif-
ference bet ween the proportions of ears 
found to have effusion by otoscopy and 
by tympanometric probability of effu-
sion should be zero on the average. The 
top frame in Fig 2 shows this difference 
in probability (vertical axis) plotted 
against the tympanometric probability 
of effusion (horizontal axis) for two con-
ditions: (1) other ear without effusion 
(solid circles) and (2) other ear with ef-
fusion (open circles). In the absence of 
bias, both of these plots should fluctuate 
randomly around a line of zero differ-
ence. However , for every tympanogram 
type, the probability that the otoscopist 
would find effusion in one ear was greatly 
influenced by the otoscopic findings of 
the other ear. Figure 2 (top frame, solid 
circles) shows that where the otoscopist 
found no effusion in one ear, the otos-
copist scored the second ear at a lower 
probability of effusion than the unbi-
ased probability associated with the 
given tympanogram type for that other 
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Fig 2. - Top, Probability of effusion associated with 
a given tympanogram type (P,) and difference 
between this tympanometric probability and condi-
tional probability of effusion by otoscopy (P, - Pc) 
at 4-week visit. Open circles are conditional proba-
bility differences from tympanometric probabilities 
given that the "other" ear has effusion (P~); filled 
circles are for the "other" ear being without effusion 
(P~)- Numbers in circles indicate tympanogram 
types. Data are plotted for tympanogram types with 
more than 10 observations. Bottom, The relation-
ship between P, and the difference in conditional 
probabilities by otoscopy when the "other" ear is 
with and without effusion (P! - P~)-
ear warranted. Similarly, where the 
otoscopist had scored the first ear with 
effusion, the otoscopist scored the other 
ear at a higher probability of effusion 
than the tympanogram warranted ( open 
circles). The two-sidedness of this re-
sult is strong evidence that there is in-
deed a bias in otoscopy arising from the 
otoscopist's simultaneous knowledge of 
the status of both ears (P<.001). 
We also tested to see if otoscopy was 
influenced by tympanogram type. Al-
though in the design of the experiment 
it was intended that the otoscopist be 
blind to the tympanogram type, in fact 
in practice the otoscopist frequently 
knew the outcome oftympanometry be-
fore recording the otoscopic findings . 
The bottom frame in Fig 2 shows that 
the magnitude of otoscopic bias (see pre-
ceding paragraph) varies with tympano-
gram type, being larger for ambiguous 
tympanograms (such as types 7 and 14, 
with effusion probabilities of 0.38 and 
0.47, respectively) and smaller for tym-
panograms of greater certainty (such as 
types 1, 4, 9, 12, and 13). This effect is 
significant (P = .008). 
We have thus demonstrated that there 
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Table 6. - Effects of Observer Expectations on Otoscopic Decision Making 
Coherence Between Tympanometry and Otoscopy• 
Dependence Agreement Disagreement Coherence 
Time 
Initial 441 4 0.991 
2wk 356 89 0.800 
4wk 358 87 0.804 
x'= 90.65, d/ = 2, P< .001 
Treatmentt 
AB + DA 118 33 0.792 
AB + PL 112 37 0.752 
PL + PL 128 17 0.883 
x'= 8.80, d/ = 2, P = .012 
Lateralityi 
Both ears with effusion 219 35 0.862 
Both ears without effusion 49 13 0.790 
1 ear with effusion 90 39 0.697 
x' = 14.82, di = 2, P< .001 
*Based on 445 children with matching data for otoscopy and tympanometry. 
tResults at 4-week visit by treatment groups: AB + DA (amoxicillin with decongestant-antihistamine combination), 
AB + PL (amoxicillin with placebo), and PL + PL (placebo with placebo). 
tLaterality by tympanometric results at 4-week visit. 
is a systematic bias in otoscopy arising 
from at least two factors: (1) the otos-
copist's simultaneous knowledge of the 
condition of both ears before recording 
and (2) the otoscopist's knowledge of 
the tympanogram type. 
We also investigated the relationship 
between the curing of ears vs the curing 
of patients with bilateral disease. Effi-
cacies (difference between the placebo 
and the antibiotic groups) for ears alone 
were very similar by otoscopy and tym-
panometry (9. 9% vs 7.2%, respectively). 
Significant differences in efficacies be-
tween otoscopy and tympanometry ap-
peared when the patient was the ex-
perimental unit (11.4% vs 3. 7%). For 
otoscopy, the efficacy for patients is 
11.4%, which is 15% larger than the 9.9% 
efficacy for ears. This is a most curious 
and unlikely result. If there were a per-
fect correlation between curing ears and 
curing patients (every patient with bi-
lateral disease in whom one ear was 
cured was also a patient in whom both 
ears were cured), then the efficacy of 
curing ears and the efficacy of curing 
patients would be the same. One would 
expect, however, that the efficacy for 
curing ears is always higher than that 
for curing patients (because of the pres-
ence of patients with bilateral disease 
who had clearance in only one ear). It is 
not logically possible to have the patient 
efficacy rate higher than that for ears 
alone. For tympanometry, the patient 
efficacy rate is 3. 7%, which is lower than 
the ear efficacy of7.2%. There is, there-
fore, sound reason to be suspicious of 
the otoscopic data produced by this ex-
periment. 
Observer Expectations 
Biasing Otoscopy 
We also investigated the possible con-
founding effects of other observer ex-
pectations on the outcome. Since the 
tympanometric method is essentially a 
machine-made recording, we assumed 
that it would not be influenced by ob-
server expectations. Also, the tympano-
gram patterns used in the diagnostic 
decision making were externally vali-
dated. Using the coherence (agreement 
or disagreement) between the two meth-
ods of diagnosis as the measure, we 
tested three elementary hypotheses con-
cerning observer expectations: (1) mid-
dle-ear effusions resolve after some time; 
(2) medically treated children will do 
better than untreated children; and (3) 
if the observer sees one effusion-free 
ear first, chances of finding a contralat-
eral effusion-free ear are higher. 
The findings of this investigation are 
shown in Table 6. All the above three 
factors demonstrated significantly dif-
ferent coherence values between the two 
methods, suggesting a strong observer 
expectation effect. The time effect on 
observer expectations is illustrated in 
the first panel. At entry to the study, 
the two methods were almost in total 
agreement (coherence, 99%); however, 
by 2 weeks, agreement was only 80% 
(P< .001). The second panel shows the 
effect of treatment assignment on ob-
server expectations. At 4 weeks, coher-
ence for the placebo-treated group was 
88%, which was significantly higher than 
coherence values for the two antibiotic-
treated groups (P = .012). Although the 
observers were blinded to treatment as-
signments, some unknown factors such 
as reported side effects or conversations 
with parents might have induced clues 
about the assignment, thus influencing 
the observer. The presence of a single 
disease-free ear is more likely to pro-
duce an otoscopic deci,;ion of a disease-
free child. The third panel in Table 6 
shows that in unilateral effusion (by tym-
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panometry) the coherence between the 
two measures was 70%, which was sig-
nificantly different from the coherence 
when subjects had either bilateral effu-
sions or bilateral effusion-free ears 
(P = .001). 
Another problem associated with oto-
scopic findings is the cure rate differ-
ence between placebo- and antibiotic-
treated groups in unilateral disease that 
exceeds the possible physiologic upper 
bound. The most plausible mode of ac-
tion of antimicrobials in resolving secre-
tory otitis media is the sterilization of 
effusion from pathogenic bacteria. Al-
though it is not documented, if steril-
ization and clearance are related, then it 
may be possible to estimate the maxi-
mum efficacy of amoxicillin and to de-
termine the upper bound for cure-rate 
differences between placebo-treated and 
antimicrobial-treated groups. 
It was reported that H aemophilus in-
fluenzae and Streptococcus pneumoniae, 
the two amoxicillin-sensitive pathogenic 
bacteria, were isolated in 16% of the 
effusions from ears with secretory otitis 
media. 11 Also, it has been shown that 
amoxicillin is 83% effi cient in eradicat-
ing these two species of microorganism 
in acute otitis media. 13 Using these two 
figures, the upper bound or the maxi-
mum differences between the two treat-
ment groups would be about 13% when 
ears are used as the experimental unit 
if the sterilization concept is the only 
operative mechanism. 
According to tympanometric findings, 
the ear-based cure-rate differences 
among the placebo and amoxicillin 
groups were 7.2% for bilateral disease 
and 13.5% for unilateral disease, which 
is within the limits of the hypothesis of 
pathogenic bacteria eradication. How-
ever, by otoscopic results, the differ-
ences were 9.5% for bilateral disease 
and 15. 7% for unilateral disease. There-
fore , otoscopic findings for children with 
unilateral disease who were treated with 
amoxicillin are beyond this upper bound 
and not possible to explain by this hy-
pothesis - sterilization of the effusion. 
These observations support our ar-
gument that the tympanometric results 
are more valid than the otoscopic find-
ings and that otoscopy as employed in 
this study has a systematic bias. Fur-
thermore, the arguments and evidence 
provided above suggest that estimates 
of antibiotic efficacy by otoscopy for the 
bilateral effusions cannot be valid, and 
estimates for the unilateral disease are 
an unlikely physiologic possibility. 
Therefore, averaging of the otoscopic 
and tympanometric measures is unlikely 
to contribute to our understanding of 
the efficacy ofantibiotics. It is our judg-
ment that science is better served by 
the exclusion of the present otoscopic 
results. 
Comparison With Other Studies 
The children treated with amoxicillin 
in the present study had less frequent 
resolution of effusion at 4 weeks than 
the values reported by other uncon-
trolled clinical trials evaluating the ef-
fi cacy of various antimicrobials for otitis 
media with effusion.21-26 With the ex-
ception of the OMRC clinical trials, com-
parison of the present findings with other 
studies will be difficult since the diag-
nostic accuracy, measures for outcome, 
patient selection criteria, study design, 
choice of antibiotics, and duration of 
treatment were all different between 
the studies. Furthermore, none of the 
previous studies used a placebo-con-
trolled, double-blind , randomized study 
design with a large cohort of subjects to 
balance the distribution of prognostic 
factors. Five of the six previous reports 
demonstrating significant benefit of an-
timicrobial treatment (cure rate range, 
45% to 65%) did not include a placebo 
control group, and the only study with 
a placebo group used a nasal deconges-
tant treatment as placebo and was lim-
ited to 51 subjects. 21 As demonstrated 
in Tables 3 and 4, even in a large ran-
domized study like the present one, the 
combined effects of treatment, diagnos-
tic accuracy, and prognostic factors must 
be analyzed very carefully before reach-
ing efficacy conclusions. 
In two recent placebo-controlled clin-
ical trials, it was claimed that antibiot-
ics are effective in the treatment of child-
hood secretory otitis media. Thomsen 
et al29 concluded in 1989 that a 1-month 
course of Augmentin (amoxicillin with 
clavulanate) is effective for the treat-
ment ofotitis media. One ofus (E. I. C.) 
has already published a critical exami-
nation of this article, 41 questioning the 
conclusion of Thomsen et al on Aug-
mentin efficacy for otitis media with ef-
fusion. Otten and Grote30 reported in 
1990 that a 10-day amoxicillin therapy is 
efficacious for otitis media with effusion 
in children with concurrent chronic rhi-
nosinusitis. However, their published 
(refereed) article shows that after 
6 weeks of follow-up the amoxicillin-and 
placebo-treated groups had cure rates 
of 5.3% and 7.9%, respectively. This is 
a curious result considering the efficacy 
conclusions of the authors. 
CONCLUSIONS 
Of the seven different measures of 
outcome, otoscopy, notwithstanding the 
questions about its validity, was the only 
measure that showed significant differ-
ences favoring the antibiotic-treated 
group at the 4-week visit. Outcome, as 
measured by the remaining six methods 
including tympanometry, combination 
oftympanometry with otoscopy, and im-
provement in hearing, was equivocal. 
Furthermore, recurrence rates were sig-
nificantly higher in the antibiotic-treated 
group than in the placebo group. Six 
weeks after antibiotic treatment, the 
number of children without effusion was 
about the same in each group. We con-
clude, therefore, that amoxicillin is not 
effective for the treatment of persistent 
asymptomatic middle-ear effusions. 
Recent publications indicate that an-
timicrobial treatment is not effective 
even for acute otitis media. 14-19 Our re-
examination of the study by Mandel et 
al is consistent with those recent find-
ings-ineffectiveness of antibiotic treat-
ment for acute otitis media. Our results 
also confirm the conclusions of the pre-
viously reported lack of efficacy of a 
decongestant-antihistamine combination 
for otitis media with effusion. 2 
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